Multi-bed vascular disease and atherothrombosis: Scope of the problem

Journal of Thrombosis and Thrombolysis

Volumn 17, Issue 1, 2004, Pages 51-61

  Duvall, William Lane ^a   Vorchheimer, David A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cerebrovascular disease; Coronary heart disease; Peripheral arterial disease

Indexed keywords

CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; STROKE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; THROMBOSIS; UNITED STATES; VASCULAR DISEASE;

ARTERIOSCLEROSIS; HUMANS; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; THROMBOSIS;

EID: 4043177026     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000036029.56317.d1     Document Type: Article

References (48)

1. Virchow IV. Thrombose und Embolie. In Gesammelte Abhandlungen zur Wissentschaftlichen Medizin. Meidinger Sohn, Berlin, 1856:495-507.
2. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea: Preliminary report. JAMA 1953 152:1090-1093.
3. Aldons JL. Atherosclerosis. Nature 2000;407:233-241.
4. Kadar A, Glasz T. Development of atherosclerosis and plaque biology Cardiovascular Surgery 2001;9:109-121.
5. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak and intermediate lesions of arteriosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis American Heart Association. Circulation 1994;89:2462-2478.
6. Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of advanced arteriosclerotic lesions and a classification of arteriosclerosis. Circulation 1995;92:1355-1374.
7. Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis American Heart Association. Circulation 1992;85:391-405.
8. Wilson PF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
9. Wolf PA, D'Agostino RB, Belanger AJ, et al. Probability of stroke: A risk profile from the Framingham study Stroke 1991;3:312-318.
10. Murabito JM, D'Agostino RB, Silberschatz, Wilson PF. Intermittent claudication: A risk profile from the Framingham Heart Study Circulation 1997;96:44-49.
11. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex.: American Heart Association, 2001.
12. World Health Organization. Combating the Tobacco Epidemic. WHO's World Health Report, 1999. Geneva, Switzerland: World Health Organization, 1999.
13. National Heart, Lung, and Blood Institute. The Sixth Report of the Joint Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH publication no. 98-4080 (1997).
14. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998 21:1414-1431.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
16. WHO-MONICA Project: Myocardial infarction and coronary deaths in the World Health Organization Monica Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in 4 continents. Circulation 1994;90:583-612.
17. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001 286:1317-1324.
18. National Center for Health Statistics. Final Mortality Data for 1999. National Vital Statistics System Table LCWK1. Hyattsville, MD, 1999.
19. Rosamond WD, Folsom AR, Chambless LE, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999 30:736-743.
20. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985 71:510-515.
21. Stoffers HE, Kaiser V, Knotterus JA. Prevalence in general practice. In: Fowkes FR, ed. Epidemiology of peripheral vascular disease. London: Springer-Verlag, 1991:109-115.
22. Criqui MH. Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol 2001 ;88(Suppl):43J-47J.
23. Criqui MH. Epidemiology and prognostic significance of peripheral arterial disease. In: Hirsch AT, ed. Primary Care Series: Peripheral Arterial Disease and Intermittent Claudication. NJ, Exerpta Medica, Inc, 2001:5-11.
24. Thorn TJ, Kannel WB, Silbershatz H, D'Agostino RB. Cardiovascular diseases in the United States and prevention approaches. In: Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's the Heart, 10th ed. New York: McGraw-Hill 2001:3-17.
25. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease. J Vasc Surg 2000;1(Suppl):1-296.
26. Wolfe JN. Defining the outcome of critical ischaemia: A one year prospective study. Br J Surg 1986;73:321.
27. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991 87:119-128.
28. National Center for Health Statistics: Health, United States, 1998, with Socioeconomic Status and Health Chartbook. Hyattsville, MD, NCHS, 1998.
29. Wyngard DL, Barrett-Connor E. Heart disease and diabetes. In: Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health, 1995, NIDDK, NIH Pub. No. 95-1468.
30. Ross, R. The pathogenesis of arteriosclerosis: A perspective for the 1990's. Nature 1993;362:801-809.
31. The World Health Report. Making a Difference. Geneva: World Heath Organization; 1999.
32. The WHO MONICA Project: A worldwide monitoring system for cardiovascular disease. World Health Stat Ann 1989;27:149.
33. The WHO MONICA Project: Myocardial infarction and coronary deaths in the WHO MONICA Project. Circulation 1994;90:583-612.
34. National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2000 Chartbook on Cardiovascular Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health, 2000.
35. Fuster V. Epidemic of cardiovascular disease and stroke: Three main challenges. Circulation 1999;99:1132-1137.
36. Murray JL, Lopez AD. Global burden disease study. Lancet 1997 349:1269-1276,1436-1442.
37. Ounpuu S, Anand S, Yusuf S. The impending global epidemic of cardiovascular disease. European Heart Journal 2000;21:880-883.
38. Murray CJ, Lopez AD, eds. The global burden of disease: A comprehensive assessment of mortality and disability from disease, injuries, and risk factors in 1990 and projected to 2020. USA, Harvard School of Health, 1996.
39. Omran AR. The epidemiologic transition: A theory of the epidemiology of population change. Millbank Memorial Fund Q 1971;49:509-538.
40. Hughson WG, Mann JI, Tibbs DJ, et al. Intermittent claudication: Factors determining outcome. BMJ 1978;1:1377-1379.
41. Szilagyi DE, Hageman JH, Smith RF, et al. Autogenous vein grafting in femoropopliteal atherosclerosis: The limits of its effectiveness. Surgery 1977;86:836-851.
42. Vecht RJ, Nicolaides AN, Brandao E, et al. Resting and treadmill electrocardiographic findings in patients with intermittent claudication. Int J Angiol 1982;1:119-121.
43. Brewster DC, Okada RD, Strauss HW, et al. Selection of patients for preoperative coronary angiography: Use of dipyridamole-stress-thallium myocardial imaging. J Vasc Surg 1985;2:504-510.
44. Valentine RJ, Grayburn PA, Eichhorn EJ, et al. Coronary artery disease is highly prevalent among patients with premature peripheral vascular disease. J Vasc Surg 1994;19:668-674.
45. Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984;199:223-233.
46. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996;23:645-649.
47. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996 348:1329-1339.
48. Ouriel K. Peripheral arterial disease. Lancet 2001; 358:1257-1264.